Genmab A (GMAB) Current Assets (2019 - 2026)

Genmab A has reported Current Assets for 6 years, with the latest figure at $2.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 36.26% year-over-year to $2.6 billion; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (down 36.26% YoY), and the FY2025 full-year result was $2.9 billion, down 26.03% from the prior year.
• Current Assets for Q1 2026 stood at $2.6 billion, down from $2.9 billion in the prior quarter.
• The five-year high for Current Assets was $4.9 billion in Q4 2023, with the low at -$2.5 billion in Q1 2024.
• Historically, Current Assets has averaged $3.1 billion across 4 years, with a median of $3.9 billion in 2024.
• Annual changes were most pronounced in 2025 — Current Assets jumped 260.58% — and 2026, when it sank 36.26%.
• Genmab A's Current Assets stood at $4.9 billion in 2023, then slipped by 20.6% to $3.9 billion in 2024, then dropped by 26.03% to $2.9 billion in 2025, then declined by 10.81% to $2.6 billion in 2026.
• The last three Current Assets figures came in at $2.6 billion (Q1 2026), $2.9 billion (Q4 2025), and $4.5 billion (Q3 2025), per Business Quant data.